| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $57.2M | -21.9% |
| SG&A Expense | $12.8M | -7.0% |
| Operating Income | -$70.1M | +19.5% |
| Pre-tax Income | -$67.0M | +17.7% |
| Income Tax | $585K | — |
| Net Income | -$67.6M | +17.0% |
| EPS (Basic) | -$1.81 | +54.5% |
| EPS (Diluted) | -$1.81 | +54.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $47.2M | -33.1% |
| Current Assets | $48.0M | -32.9% |
| Total Assets | $49.1M | -32.5% |
| Current Liabilities | $14.1M | +11.0% |
| Stockholders' Equity | $35.0M | -41.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$60.3M | -37.8% |
| Investing Cash Flow | $49.0M | +0.0% |
| Financing Cash Flow | $37.2M | — |